BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22526624)

  • 1. Transdifferentiation: a cell and molecular reprogramming process.
    Sisakhtnezhad S; Matin MM
    Cell Tissue Res; 2012 Jun; 348(3):379-96. PubMed ID: 22526624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct reprogramming of adult somatic cells into other lineages: past evidence and future perspectives.
    Nizzardo M; Simone C; Falcone M; Riboldi G; Comi GP; Bresolin N; Corti S
    Cell Transplant; 2013; 22(6):921-44. PubMed ID: 23044010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular reprogramming during mouse development.
    Burke ZD; Miron-Buchacra G; Tosh D
    Results Probl Cell Differ; 2012; 55():291-302. PubMed ID: 22918813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can controlled cellular reprogramming be achieved using microRNAs?
    Sun X; Fu X; Han W; Zhao Y; Liu H
    Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine.
    Eguizabal C; Montserrat N; Veiga A; Izpisua Belmonte JC
    Semin Reprod Med; 2013 Jan; 31(1):82-94. PubMed ID: 23329641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regeneration and reprogramming.
    Knapp D; Tanaka EM
    Curr Opin Genet Dev; 2012 Oct; 22(5):485-93. PubMed ID: 23084810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell plasticity in Caenorhabditis elegans: from induced to natural cell reprogramming.
    Hajduskova M; Ahier A; Daniele T; Jarriault S
    Genesis; 2012 Jan; 50(1):1-17. PubMed ID: 21932439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concise review: Oct4 and more: the reprogramming expressway.
    Sterneckert J; Höing S; Schöler HR
    Stem Cells; 2012 Jan; 30(1):15-21. PubMed ID: 22009686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming into pancreatic endocrine cells based on developmental cues.
    Kordowich S; Mansouri A; Collombat P
    Mol Cell Endocrinol; 2010 Jul; 323(1):62-9. PubMed ID: 20025937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introducing transcription factors to multipotent mesenchymal stem cells: making transdifferentiation possible.
    Barzilay R; Melamed E; Offen D
    Stem Cells; 2009 Oct; 27(10):2509-15. PubMed ID: 19591229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of some donor-host cell interactions in conditions of the regenerative process microenvironment].
    Shabliĭ VA; Lukash LL; Lobintseva HS
    Tsitol Genet; 2012; 46(3):65-74. PubMed ID: 22856147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New strategy for conversion of cell function: lineage reprogramming].
    Wang P; Tang QS; Chen LP
    Sheng Li Ke Xue Jin Zhan; 2010 Oct; 41(5):359-61. PubMed ID: 21416926
    [No Abstract]   [Full Text] [Related]  

  • 13. Reprogramming with defined factors: from induced pluripotency to induced transdifferentiation.
    Masip M; Veiga A; Izpisúa Belmonte JC; Simón C
    Mol Hum Reprod; 2010 Nov; 16(11):856-68. PubMed ID: 20616150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-fusion-mediated reprogramming: pluripotency or transdifferentiation? Implications for regenerative medicine.
    Sanges D; Lluis F; Cosma MP
    Adv Exp Med Biol; 2011; 713():137-59. PubMed ID: 21432018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering Cell Fate for Tissue Regeneration by In Vivo Transdifferentiation.
    de Lázaro I; Kostarelos K
    Stem Cell Rev Rep; 2016 Feb; 12(1):129-39. PubMed ID: 26403511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.
    Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J
    Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells.
    Pournasr B; Khaloughi K; Salekdeh GH; Totonchi M; Shahbazi E; Baharvand H
    Stem Cells; 2011 Dec; 29(12):1933-41. PubMed ID: 21997905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regeneration through reprogramming adult cell identity in vivo.
    Smith DK; Zhang CL
    Am J Pathol; 2015 Oct; 185(10):2619-28. PubMed ID: 26056931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incomplete MyoD-induced transdifferentiation is associated with chromatin remodeling deficiencies.
    Manandhar D; Song L; Kabadi A; Kwon JB; Edsall LE; Ehrlich M; Tsumagari K; Gersbach CA; Crawford GE; Gordân R
    Nucleic Acids Res; 2017 Nov; 45(20):11684-11699. PubMed ID: 28977539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical transdifferentiation: closer to regenerative medicine.
    Xu A; Cheng L
    Front Med; 2016 Jun; 10(2):152-65. PubMed ID: 27142989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.